Demeclocycline as a contrast agent for detecting brain neoplasms using confocal microscopy

Area of Science:

• Neurosurgery
• Oncology
• Medical Imaging

Background:

• Complete resection of brain tumors is crucial for improving patient survival and quality of life.
• Accurate intraoperative detection and precise removal of brain neoplasms are essential for successful surgical outcomes.
• Novel contrast agents are needed to enhance the visualization of brain tumors during surgery.

Purpose of the Study:

• To evaluate demeclocycline as a potential contrast enhancer for intraoperative brain tumor detection.
• To assess the efficacy of demeclocycline in distinguishing between normal and neoplastic brain tissues.
• To investigate the utility of multimodal confocal microscopy in conjunction with demeclocycline staining.

Main Methods:

• Freshly excised brain tissues (pituitary adenoma, meningiomas, glioblastomas, metastatic cancers) were stained with demeclocycline.
• Multimodal confocal microscopy was used, acquiring reflectance images at 402 nm and fluorescence signals (500–540 nm).
• Optical images were correlated with histological sections for validation.

Main Results:

• Fluorescence imaging effectively highlighted both normal and cancerous brain cells.
• Reflectance imaging provided detailed visualization of connective tissue morphology.
• A strong correlation was observed between optical imaging findings and subsequent histological analysis across all tumor types.

Conclusions:

• Demeclocycline demonstrates significant potential as a contrast agent for intraoperative brain tumor detection.
• The combination of demeclocycline staining and multimodal confocal microscopy offers a promising approach for enhanced surgical guidance.
• This method aids in achieving microscopically controlled removal of brain neoplasms, improving surgical precision.